Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $4.37 and traded as low as $4.20. Galmed Pharmaceuticals shares last traded at $4.54, with a volume of 121,399 shares.
Analyst Ratings Changes
Separately, StockNews.com began coverage on Galmed Pharmaceuticals in a research report on Wednesday, October 9th. They issued a “sell” rating for the company.
Get Our Latest Analysis on Galmed Pharmaceuticals
Galmed Pharmaceuticals Stock Down 5.6 %
Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) last posted its quarterly earnings data on Wednesday, August 28th. The biopharmaceutical company reported $2.16 earnings per share for the quarter.
Galmed Pharmaceuticals Company Profile
Galmed Pharmaceuticals Ltd., a biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus.
Read More
- Five stocks we like better than Galmed Pharmaceuticals
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- How to Calculate Return on Investment (ROI)
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Galmed Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Galmed Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.